Scotts Miracle-Gro Co’s (NYSE: SMG) shares have declined by 25% over the month, with concerns around store closures and leverage, according to BofA Securities.
The Scotts Miracle-Gro Analyst
Christopher Carey maintained a Buy rating for Scotts Miracle-Gro, with a price target of $135.
The Scotts Miracle-Gro Thesis
To some extent, the recent pullback in Scotts Miracle-Gro’s stock was company specific, Carey said. He cited two reasons for Wall Street’s concerns.
First, prospects of a shutdown in key home and hardware stores, which is a major risk to seasonal lawn and garden products. The analyst pointed out, however, that around 60% of Scotts Miracle-Gro’s sales were generated from Home Depot Inc (NYSE: HD), Lowe's Companies, Inc. (NYSE: LOW) and Walmart Inc (NYSE: WMT) and these stores are deemed critical and will remain open.
See Also: 7 Cannabis Stocks To Buy, Sell And Hold
The second major concern is around the company’s leverage, but Scotts Miracle-Gro has “ample earnings power to cut a turn from leverage and buy back stock, if desired.”
Carey said the company’s fundamental outlook remains intact and may even be better in some segments, while its valuation has taken a big hit amid the broader market sell-off.
Weather has been favorable and the growing number of people being housebound is likely to benefit the garden and hydroponic segments, given the rise in cannabis demand, the analyst said.
SMG Price Action
Shares of Scotts Miracle-Gro had declined by 4% to $85.87 at time of publication Friday.
Latest Ratings for SMG
|Mar 2020||Raymond James||Upgrades||Market Perform||Strong Buy|
|Feb 2020||JP Morgan||Maintains||Neutral|
|Oct 2019||Bank of America||Upgrades||Neutral||Buy|
View More Analyst Ratings for SMG
View the Latest Analyst Ratings
See more from Benzinga
- Wells Fargo Upgrades Uber, Sees More Compelling Price
- Baird Starts Coverage Of CyberArk Software On The Sidelines On Lower Market Spend
- PagerDuty Aims For Growth Despite Uncertainty, Analysts Say After Q4 Report
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.